Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Female patients aged above 18 years Patients with all stages and grades of Breast Cancer
Exclusion criteria
Exclusion criteria: Patients with Type 1 Diabetes Mellitus. Patients with other malignancies. Patients with unusual histologies, such as phyllodes tumor, sarcomas, etc. Patients with missing HbA1c values on follow-up, receptor status Patients lost to follow-up after diagnosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will compare the breast cancer outcomes such as survival, rehospitalization, recurrence, metastasis among Type 2 Diabetes and non-Type 2 Diabetes patients.Timepoint: Baseline is at the time of diagnosis, then every three months until the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| The study will assess the various factors that influence the breast cancer outcomes. Factors influencing Breast cancer outcome include: Age Comorbidities Hormone receptor status (ER, PR, HER2) Tumour stage, grade, size, position Menopausal status Lymph node status Breast cancer treatmentTimepoint: Baseline is at the time of diagnosis, then every three months until the end of treatment. | — |
Countries
India
Contacts
Public ContactDr Roopa Satyanarayan Basutkar
NGSM Institute of Pharmaceutical Sciences
Outcome results
None listed